KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

GoodRx Holdings (GDRX) Depreciation & Amortization (IS) (2019 - 2026)

GoodRx Holdings' Depreciation & Amortization (IS) history spans 7 years, with the latest figure at $23.1 million for Q4 2025.

  • On a quarterly basis, Depreciation & Amortization (IS) rose 21.21% to $23.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $85.2 million, a 22.55% increase, with the full-year FY2025 number at $85.2 million, up 22.55% from a year prior.
  • Depreciation & Amortization (IS) hit $23.1 million in Q4 2025 for GoodRx Holdings, up from $21.4 million in the prior quarter.
  • Over the last five years, Depreciation & Amortization (IS) for GDRX hit a ceiling of $43.6 million in Q4 2023 and a floor of $5.4 million in Q1 2021.
  • Historically, Depreciation & Amortization (IS) has averaged $17.6 million across 5 years, with a median of $16.0 million in 2023.
  • Biggest five-year swings in Depreciation & Amortization (IS): surged 180.74% in 2023 and later crashed 56.21% in 2024.
  • Tracing GDRX's Depreciation & Amortization (IS) over 5 years: stood at $10.6 million in 2021, then skyrocketed by 45.88% to $15.5 million in 2022, then surged by 180.74% to $43.6 million in 2023, then crashed by 56.21% to $19.1 million in 2024, then grew by 21.21% to $23.1 million in 2025.
  • Business Quant data shows Depreciation & Amortization (IS) for GDRX at $23.1 million in Q4 2025, $21.4 million in Q3 2025, and $19.7 million in Q2 2025.